XNAS: RLMD
Relmada Therapeutics Inc Live Stock Price Today, Share Analysis and Chart
about
Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently...
Read More
6.89
0.16
(2.38%)
1.4M
XNAS Volume
XNAS 22 Jun, 2026 5:30 PM (EDT)
Not Eligible
Expensive Valuation
Technically Moderately Bullish
Relmada Therapeutics Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..